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Innate immune deficiencies result in a spectrum of severe clinical outcomes following infection. In
particular, there is a strong association between loss of the signal transducer and activator of transcrip-
tion (Stat) pathway, breach of the blood-brain barrier (BBB), and virus-induced neuropathology. The gene
signatures that characterize resistance, disease, and mortality in the virus-infected nervous system have
not been defined. Herpes simplex virus type 1 (HSV-1) is commonly associated with encephalitis in
humans, and humans and mice lacking Stat1 display increased susceptibility to HSV central nervous
system (CNS) infections. In this study, two HSV-1 strains were used, KOS (wild type [WT]), and vhs, an
avirulent recombinant lacking the virion host shutoff (vhs) function. In addition, two mouse strains were
used: strain 129 (control) and a Stat1-deficient (Stat1/) strain. Using combinations of these virus and
mouse strains, we established a model of infection resulting in three different outcomes: viral clearance
without neurological disease (vhs infection of control mice), neurological disease followed by viral
clearance (vhs infection of Stat1/ mice and WT infection of control mice), or neurological disease
followed by death (WT infection of Stat1/ mice). Through the use of functional genomics on the infected
brain stems, we determined gene signatures that were representative of the three infection outcomes. We
demonstrated a pathological signature in the brain stem of Stat1-deficient mice characterized by upregu-
lation of transcripts encoding chemokine receptors, inflammatory markers, neutrophil chemoattractants,
leukocyte adhesion proteins, and matrix metalloproteases. Additionally, there was a greater than 100-fold
increase in the inflammatory markers interleukin 1 (IL-1) and IL-6. Consistent with this gene signa-
ture, we demonstrated profound CNS inflammation with a concomitant lethal breach of the BBB. Taken
together, our results indicated an essential role for normal Stat1-dependent signaling in mediating a
nonpathological immune response to viral CNS infection.
Virus infection of the human central nervous system
(CNS) is a significant source of morbidity and mortality
worldwide. While both innate and adaptive immunity are
essential for protection of the CNS, the immune response is
also capable of causing significant collateral damage during
and after clearance of infection (6, 27). As with other tis-
sues, viral infection of the CNS is recognized by Toll-like
receptors (TLRs) and other pattern recognition receptors
(PRRs) that activate antiviral host defenses. Multiple sig-
naling pathways are activated, including NF-B, MAPK, and
interferon (IFN), which initiate expression of inflammatory
cytokines and chemokines (reviewed in references 1 and 62).
In response, immune cells, including monocytes, neutro-
phils, natural killer cells, dendritic cells, and T cells, che-
motactically migrate into the infected brain. Migration of
cells into the CNS is controlled by the blood-brain barrier
(BBB), a highly selective structure composed of endothelial
cells, neurons, pericytes, and astrocytes that controls the
migration and diffusion of molecules and cells from the
vasculature into the parenchyma (reviewed in reference 17).
CNS control and clearance of a viral infection can depend
on the ability of immune cells and molecules to cross this
barrier (47, 49). A pivotal aspect of a successful immune
response is the balance between efficacy and pathology, and
we hypothesize that the achievement of such a balance is
critical in nonregenerative organs, such as the brain.
Herpes simplex virus type 1 (HSV-1) is a ubiquitous, neu-
rotropic human pathogen that causes mostly self-limiting dis-
eases in immunocompetent hosts but can cause encephalitis,
meningitis, and hepatitis in immune-suppressed hosts (36, 42).
Herpes simplex encephalitis (HSE) is the most common form
of viral sporadic encephalitis (25) and, when left untreated, has
a mortality rate of 70% (3, 22). HSE may result from primary
infection or reactivation from latency, and it frequently in-
volves frontal or temporal lobes, as well as the brain stem. HSE
has a strong association with immune pathology; hence, ste-
roids have been proposed as a treatment adjunct to antivirals
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(14). Nucleoside analogs are effective against HSE, but de-
layed diagnosis is frequent, and delayed treatment results in
increased morbidity and mortality. Even with treatment, the
1-year mortality rate from HSE is 14%, with frequent neuro-
logical sequelae in survivors.
The IFN signaling pathway provides an effective and rapid
antiviral host response to viral infection. Type I IFN (IFN-
and IFN-) is produced by infected cells and establishes the
antiviral state. Type II IFN (IFN-) also has multiple activities,
and it serves to activate macrophages and NK cells and ulti-
mately stimulate T-cell-mediated adaptive immunity. IFN re-
ceptor (IFNR) engagement leads to phosphorylation of asso-
ciated Janus and tyrosine kinases, which in turn phosphorylate
and activate Stat (signal transduction and transcription factor)
proteins (45). The Stat proteins then translocate to the nucleus
and initiate IFN-dependent transcription programs. While
type I IFN stimulates the phosphorylation of Stat1, Stat2, and
Stat3, type II IFN selectively induces phosphorylation of Stat1.
Stat1 is therefore critical in both type I and type II IFN sig-
naling, as it mediates expression from both IFN-stimulated
response elements (ISREs) and gamma-activated sequence
(GAS) motifs. ISRE and GAS-dependent genes are critical for
establishing both antiviral and adaptive immune responses in
response to infection, as shown by the increased susceptibility
of Stat1-deficient mice to various pathogens (10, 11, 16, 21, 28,
30, 32, 35, 48). Previously, we demonstrated that Stat1/ mice
show significantly increased HSV-driven immune pathology in
the cornea, independent of viral titer (32). Moreover, immune
pathology was apparent even following infection with a highly
attenuated HSV strain lacking the virion host shutoff (vhs)
protein, a viral RNase that degrades both host and viral
mRNA (32, 34, 41, 54). These findings, together with the im-
munopathological nature of HSE, led us to hypothesize that
Stat1 may play a role in balancing the immune response to
HSV infections in the brain.
To define gene signatures representative of a spectrum of
HSV CNS infection, we utilized infection modalities to gener-
ate three infection outcomes. We used two viruses, wild-type
HSV-1 KOS (WT) and an attenuated recombinant virus lack-
ing the vhs function (vhs), and two mouse strains, control
mice and Stat1/ mice. The three outcomes were subclinical
infection (by vhs infection of control mice), infection fol-
lowed by neurological disease and recovery (by vhs infection
of Stat1/ mice and WT infection of control mice), and in-
fection followed by neurological disease and death (by WT
infection of Stat1/ mice). We examined gene profiles in both
diseased and protected CNS tissues and generated pathologi-
cal and protective gene signatures that represent causation or
prevention of neurological disease. We directly correlated neu-
rological disease and gene signatures with in vivo data demon-
strating increased immune cell infiltrates, BBB leakage, and
changes in cytokine expression profiles. These data therefore
revealed a critical dependence upon fully functional Stat1 to
specifically protect the nervous system from neurotropic virus
infection and associated immune pathology. In addition, this
work provides a gene signature framework for diagnosis and
prediction of clinical outcomes following virus infection of the
brain.
MATERIALS AND METHODS
Ethics statement. Animal treatment was consistent with the National Insti-
tutes of Health guidelines (30a). All experimental procedures were approved by
the Washington University and Dartmouth Medical School Institutional Animal
and Care Use Committees.
Cells, viruses, and mice. Vero cells were used for amplification and titering of
viral stocks as previously described (40). All viruses used in this study were of the
KOS background (50). Construction of the vhs-null HSV-1 (vhs) virus has been
previously described (54). Mock-treated animals were inoculated with uninfected
Vero cell lysates prepared in a manner parallel to that used for infected Vero
lysates. Mouse strains used were 129S6 (as control mice) (Taconic Farms, Ger-
mantown, NY) and 129S6 Stat1 knockout mice (Stat1/) (28). Mice were
housed in the Washington University School of Medicine enhanced barrier
facility and were infected in the Washington University School of Medicine
biohazard facility. At both facilities, sentinel mice were screened every 3 months
and determined to be negative for adventitious mouse pathogens, in particular
mouse norovirus. Mice were infected between 6 and 8 weeks of age. Mice were
housed, treated, and euthanized when necessary in accordance with all federal
and university policies. All animal studies were reviewed and approved by the
Washington University Animal Studies (protocol number 2005-0234).
Animal infection procedures. For corneal infection, equivalent numbers of
male and female mice were anesthetized intraperitoneally (i.p.) with ketamine
(87 mg/kg body weight) and xylazine (13 mg/kg). Corneas were bilaterally scar-
ified with a 25G syringe needle, and virus was inoculated by adding 2  106 PFU
in a 5-l volume per eye. Brain stem and liver were harvested from sacrificed
mice on the indicated day postinfection, mechanically disrupted with 3-mm glass
beads, and sonicated before tissue titers were determined on Vero cells (as
PFU/tissue). For both viruses and each time point, at least eight animals were
measured, with samples collected from at least 3 independent groups of the 2
different strains of mice. All titer values are expressed as mean 	 standard error
of the mean (SEM). Statistical significance was determined using the nonpara-
metric Mann-Whitney U test, with values of P 
 0.05 considered statistically
significant.
Histological analysis. At the specified day postinfection, brain stems were
harvested from sacrificed mice and immediately fixed in 10% buffered neutral
formalin. Paraffin-embedded brain stems were sagitally sectioned and counter-
stained with hematoxylin. HSV antigen was detected with an anti-HSV-1 rabbit
polyclonal antibody (Dako, Denmark). Primary antibodies were detected with
streptavidin-horseradish peroxidase (HRP) and diaminobenzidine (DAB). Sec-
tions were imaged at 20.
Bead-based multiplex cytokine analysis. Brain stems were harvested from
mock-treated or infected mice at the indicated day postinfection and stored at
80°C in PBS until processing. Thawed samples were mechanically disrupted
with 3-mm glass beads and sonicated. Large debris was removed by centrifuga-
tion for 5 min at 500  g at 4°C. The resulting supernatant was clarified by
centrifugation for 5 min at 14,000  g at 4°C. An aliquot of the supernatant was
mixed 1:1 with the Bio-Rad serum diluent solution (Bio-Rad, Hercules, CA). A
Bradford assay was utilized to normalize protein levels. The bead-based cytokine
BioPlex assay was performed according to the kit protocol (Bio-Rad). Cytokine
concentrations were quantified by comparison to a standard curve and are
reported as pg/ml. Results shown are the averages from at least two experiments,
with each experiment containing 2 or more mice per data point (n  4).
EB dye uptake assay to measure blood-brain barrier integrity. On the indi-
cated days postinfection, 1 h prior to sacrifice, 300 l of 2% Evans blue (EB) in
saline (wt/vol) was administered i.p. Extremities were examined for coloration to
confirm proper EB delivery. After 1 h, mice were euthanized with CO2 and
immediately perfused with 50 ml phosphate-buffered saline (PBS). Mice not fully
perfused were not included in the results. Brain and brain stem were removed
and homogenized in 1 ml PBS. EB dye was precipitated with an equal volume of
100% trichloroacetic acid (TCA) on ice for 30 min. Samples were centrifuged at
2,800  g for 30 min at 4°C, and the optical density at 620 nm (OD620) absor-
bance was measured on supernatants (64). Uptake of dye, as indicated by an
increase in A620, correlates with increased blood-brain barrier permeability.
RNA preparation and oligonucleotide microarray processing. At the indicated
day postinfection, mice were sacrificed, brain stems harvested and homogenized,
and RNA was extracted as previously described (32). RNA samples were spec-
troscopically verified for purity, and the quality of the intact RNA was assessed
using an Agilent 2100 bioanalyzer. cRNA probes were generated from each
sample by the use of an Agilent one-color LowInput quick amp labeling kit
(Agilent Technologies, Santa Clara, CA). Individual cRNA samples were hy-
bridized to Agilent mouse whole-genome oligonucleotide 4-by-44 microarrays
(approximately 39,000 unique mouse genes) according to the manufacturer’s
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instructions. Samples from individual animals were not pooled to enable exam-
ination of animal-to-animal variation as part of the data analysis. These included
two animals per time point for each virus (73 animals total). Select samples were
hybridized a second time (n  2 technical replicates) to verify the quality of the
process. Slides were scanned with an Agilent DNA microarray scanner, and the
resulting images were analyzed using Agilent Feature Extractor (AFE), version
8.1.1.1. The AFE software was used to perform image analysis, including signif-
icance of signal and spatial detrending, and to apply a universal error model. For
these hybridizations, the most conservative error model was applied. Raw data
were then loaded into a custom-designed laboratory information management
system (LIMS). Data were warehoused in a Labkey system (Labkey, Inc., Seattle,
WA) and analyzed using Rosetta Resolver 7.2 (Rosetta Biosoftware, Seattle,
WA) and Spotfire DecisionSite for Functional Genomics 9.1.1 software (Tibco
Spotfire, Somerville, MA).
Microarray analysis and bioinformatics. Global gene expression in infected
brain stems was compared to mock control RNA prepared from a pool of equal
masses of total RNA from brain stem tissue of two uninfected mice per time
point. Probe labeling and microarray slide hybridization were performed as
described elsewhere (5). The Resolver system creates ratio profiles by combining
replicates while applying error weighting (termed a “squeeze operation”). The
error weighting consists of adjusting for additive and multiplicative noise. A P
value is generated that represents the probability that a gene is differentially
expressed. In this study, a threshold P value of 0.01 was used to identify genes
that were significantly differentially expressed. The Resolver system then com-
bines ratio profiles to create ratio experiments using an error-weighted average
as described elsewhere (52). Spotfire Decision Site 9.1.1 (Spotfire, Somerville,
MA), and Ingenuity Pathways Analysis (IPA) 8.0 (Ingenuity Systems, Redwood
City, CA) were also used for data analysis and mining. Primary gene expression
data are available at http://viromics.washington.edu in accordance with proposed
MIAME standards. Functional and network analysis of statistically significant
gene expression changes was performed using IPA. Analysis considered all genes
from the data set that met the 2-fold (P 
 0.01) change cutoff and which were
associated with biological functions in the Ingenuity Pathways knowledge base.
For all gene set enrichment analyses, Fisher’s exact test was used to determine
the probability that each biological function assigned to the genes within each
statistical analysis was due to chance alone.
qRT-PCR. Quantitative real-time reverse transcription-PCR (qRT-PCR) was
performed on samples from individual animals to validate specific cellular gene
expression changes (CXCL10 and IFN-) detected by microarray. The Quanti-
Tect reverse transcription kit (Qiagen Inc., Valencia, CA) was used to generate
cDNA. qRT-PCR was run on an ABI 7500 PCR system, using TaqMan chemistry
(Applied Biosystems, Foster City, CA). Gene expression assays specific to mouse
cellular genes were purchased from Applied Biosystems. Differences in gene
expression are represented as log10 of the fold change of the calibrator group
relative to that of the target group (log10RQ) relative to a calibrator and nor-
malized to a reference, using the 2CT method (24, 46).
RESULTS
Virological analysis of brain stems and livers. Previous stud-
ies have shown that while KOS (WT) grows robustly in corneas
of control and Stat1/ mice, viruses lacking vhs show pro-
foundly attenuated replication relative to WT virus in both
mouse strains (35, 53, 54). To better define infection kinetics
and related gene expression changes in different tissues, we
determined the titers of virus from the brain stems and livers of
infected mice. Viral titers in the brain stems of WT-infected
control mice peaked at 5 days postinfection (dpi) and de-
creased by 7 dpi. In contrast, vhs-infected control mice had
undetectable levels of virus (Fig. 1A). Brain stems from WT-
infected Stat1/ mice showed steadily increasing viral titers
out to 7 dpi, shortly after which these mice began to die. In
contrast, virus titers in vhs-infected Stat1/ mice peaked on
day 5 and decreased thereafter, correlative with their survival.
This is consistent with previous results showing that viral
brain stem titers in vhs-infected Stat1/ mice were sig-
nificantly higher than those in control mice but significantly
lower than those in WT-infected Stat1/ mice (35). Nota-
bly, the WT virus-infected control and Stat1/ mice and
the vhs virus-infected Stat1/ mice all had significant
virus titers at 5 dpi, yet these mice presented with dramatic
differences in disease.
Like the brain stem, the liver is highly susceptible to HSV
infection in mice and humans with compromised IFN signaling
pathways (26, 31, 42) (Fig. 1B). We therefore examined the
livers of Stat1/ mice to test whether increased susceptibility
extended beyond the brain stem. Virus was not detectable in
the livers of control mice or following infection of either mouse
strain by vhs. Livers of WT virus-infected Stat1/ mice
showed detectable virus at 3 dpi, but in contrast to infection in
the brain, liver infection was undetectable by 5 dpi. Consistent
with this, WT virus was similarly cleared from the lymph nodes
and spleens of Stat1/ mice (data not shown). These results
demonstrate a difference in the ability of Stat1/ mice to
control HSV-1 infections in the liver and the brain stem.
Molecular signature associated with host protection. The
disease and virulence patterns of control and Stat1/ mice
infected with WT and vhs viruses have been previously de-
scribed. Briefly, following corneal inoculation of WT virus,
immunocompetent control mice show no neurological disease,
FIG. 1. Virological analysis of brain stems and livers. Control or
Stat1/ mice were inoculated on the cornea with 2  106 PFU/eye of
HSV-1 WT or HSV-1 vhs. At the indicated time postinfection, brain
stems (A) and livers (B) were harvested and mechanically disrupted
for a plaque assay (n  8). Titers are presented as PFU/tissue and are
the average of results for at least 8 animals. The dotted line indicates
threshold of detection (LOD). Where average values fall below the
LOD and error bars are shown, virus was detected in some samples
and not in others. Where no error bars are shown, virus in all samples
was below the LOD. Asterisks indicate ranges of statistical significance
(*, P 
 0.05; **, P 
 0.01; ***, P 
 0.001) for differences between
bracketed bars. All bars on days 3 and 5 showed statistically significant
differences from each other, with the exception of results for WT-
infected control mice and vhs-infected Stat1/ mice, which were not
significantly different.
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while infected Stat1/ mice exhibit neurological symptoms
(hunched posture, lack of controlled movement, and weight
loss) and die between 7 and 10 days postinfection (dpi) (32). In
contrast, inoculation of vhs into control mice causes little to
no disease, with significantly reduced virulence (53, 54). In
Stat1/ mice, however, vhs shows enhanced virulence (35).
To address the pathways that protect the control mice, we
performed functional genomics analysis on infected brain
stems. The goal was to identify differences in gene expression
between the nondiseased model (WT virus-infected control
mice) and the diseased models (WT or vhs virus-infected
Stat1/ mice), with the aim of finding protective gene signa-
tures. We performed a two-way analysis of variance (ANOVA)
on the gene array data comparing nondiseased and diseased
groups at 3 and 5 days postinfection. We used samples from 3
dpi because this represents the previously observed onset of
robust viral infection in the brain and samples from 5 dpi
because it corresponds to the previously observed peak viral
titer in the WT virus-infected control mice and the onset of
disease in the Stat1/ mice (35).
The majority of differentially expressed highly upregulated
genes in the WT virus-infected control mice were IFN depen-
dent (including Irgb10, Cxcl9, Igtp [Irgm3], Oasl2, Iigp2 [Irgm2
or Gtpi], Tap1, Cxcl11, Psmb9, Ifit3, Gbp3, Irf1, Irgm, Stat1,
and Irf8) (Fig. 2A). While both type I and type II IFN can
induce most of these genes, many have been shown to be
preferentially or strongly induced by type II IFN. These in-
clude, but are not limited to, the GTPases Igtp, Iigp2, and
Gbp3 (reviewed in reference 55), Cxcl9 and Cxcl11 (12, 13),
interferon transcription factors Irf1 and Irf8 (7, 8, 19, 23),
major histocompatibility complex (MHC) class II transactiva-
tor CIIta (57), Psmb9 (7), Tap 1 (7), and Stat1 (57). Cxcl10,
encoding an IFN- inducible chemokine closely related to
Cxcl9 and Cxcl11, is upregulated via IFN-independent media-
tors, which is likely why it is expressed in both control and
Stat1/ mice (reviewed in reference 29).
The genes upregulated in the control mice were further
analyzed by Ingenuity Pathways Analysis (IPA) to identify
functionally related gene networks (Fig. 2B). This led to iden-
tification of gene nodes for three IFN--inducible transcription
factors acting downstream of IFN receptors: Stat1, Irf8, and
Irf1 (7, 8, 19, 23). These data indicate a distinct protective
signature in the brain stems of the infected control mice that
centers around IFN-stimulated genes. From these results, we
conclude that the lack of Stat1 impacts not only the antiviral
response but also the establishment of a nonpathological im-
mune response in the brain stem.
Transcriptional profiling of liver tissues reveals differential
regulation of IFN-responsive genes in brain stem and liver.
Compromised IFN responses have been previously shown to
FIG. 2. Protective signature genes. Control or Stat1/ mice were inoculated on the cornea with 2  106 PFU/eye of HSV-1 WT or HSV-1 vhs
or treated with a mock lysate. At the indicated time postinfection, RNA was harvested and processed for array analysis. (A) Heat map showing
ANOVA results for differentially expressed genes within the cutoff values of 2-fold change and ANOVA P  0.01 in brain stems comparing
nondiseased (WT virus-infected strain 129 control mice) and diseased (WT virus-infected Stat1/ mice and vhs virus-infected Stat1/ mice)
models at 5 dpi. Red and black colors indicate upregulated and unchanged genes, respectively, compared to a mock-treated sample. The numbers indicate
fold changes compared to results for a mock-treated sample. (B) Functional network analysis of 5 dpi ANOVA results determined by Ingenuity Pathways
Analysis. Arrows indicate functional interactions between genes. Yellow and blue colors indicate up- and downregulated genes, respectively.
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result in severe and lethal infection of the liver (26, 33). In this
study, there was significant infection of the liver of WT-in-
fected Stat1/ mice on day 3 (Fig. 1B), yet these mice clear
HSV from liver and subsequently succumb to CNS infection.
These divergent outcomes suggested a differential role for
Stat1 in protection of the CNS and the liver. We therefore did
transcriptional profiling on livers from control and Stat1/
mice (Fig. 3). Although WT virus titers were below the thresh-
old of detection in the livers of control mice, our analysis
showed upregulation at 5 dpi of many IFN-dependent genes,
indicative of an effective immune response. More unexpect-
edly, there was upregulation of IFN-dependent genes in the
livers of the Stat1/ mice infected with WT virus. This was
seen at 3 dpi, coincident with the peak of viral titer (Fig. 1A),
and included Cxcl9, Ifi27, Ifit3, Psmb9, Ifit2, and Eif2ak2
(PKR). Many of these genes are distinct from those strongly
upregulated in the brain stems of the same mice (Fig. 2A).
Mice lacking Stat1 differed in their ability to express IFN-
stimulated genes in the liver versus the brain stem, and this
pattern of expression directly correlated with viral replication
and clearance in each tissue (Fig. 1). These results suggest a
specific requirement of Stat1 in the CNS for the generation of
a proper response to IFN signaling. To explore this further, we
examined pathological signatures of mice that exhibit severe
disease and death from HSV infection.
Molecular signature associated with pathogenicity. Stat1/
mice infected with the attenuated vhs virus exhibited disease
similar to that found in WT virus-infected Stat1/ mice, de-
spite lower viral titers and eventual viral clearance (Fig. 1A).
The similarity in disease course between the WT and vhs
virus-infected Stat1/ mice suggested a common disease pro-
cess with divergent outcomes. We had thus far identified gene
expression changes that correlated with protection, so we next
examined the transcriptional profile with the goal of identify-
ing broad pathogenic signatures that correlated with disease.
Based on the known disease pathogenesis and the time course
of viral replication (Fig. 1A) (35), we continued to examine
infection models in which substantial viral replication and dis-
ease were observed. These infection models were control mice
infected with the WT virus and Stat1/ mice infected with
either the WT or vhs virus.
Although WT virus-infected control mice lacked behavioral
changes indicative of CNS infection, there was substantial up-
regulation at 5 and 7 dpi of chemokines and immunostimula-
tory cytokines, including monocyte chemoattractant protein
(MCP)-1 (CCL2), RANTES (CCL5), MCP-3 (CCL7), MCP-2
(CCL8), CXCL9, CXCL10, and IFN- (Fig. 4A). Of particular
note was the strong upregulation of CXCL9 and CXCL11 in
the control mice. Common to control and Stat1/ mice was a
remarkable upregulation of both CXCL10 and IFN-, which
by qRT-PCR were induced by 1,000- to 10,000-fold (data not
shown).
In contrast to control mice, the brains of Stat1/ mice
showed significant upregulation of chemokine receptors, in-
flammatory markers, neutrophil chemoattractants, leuko-
cyte adhesion proteins, and matrix metalloproteases. Up-
regulation of these factors in concert could attract
leukocytes and control BBB permeability. The upregulation
of chemokine receptors in the brain is especially indicative
of increased immune infiltration through the BBB. Consis-
tent with this, the observed increases included CCR1,
CCR2, and CCR5 (chemokine receptors found on mono-
FIG. 3. Comparison of protective responses in brain stem and liver. Heat map comparing gene expression changes in the brain stems and livers
of WT virus-infected control mice and WT or vhs virus-infected Stat1/ mice at 3 and 5 dpi. Differentially expressed genes identified in the
protective gene signature analysis are shown. Red and black colors indicate upregulated or unchanged genes, respectively, compared to a
mock-treated sample. The numbers indicate fold changes compared to results for a mock-treated sample.
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cytes, macrophages, T cells, and dendritic cells), as well as
CXCL1 and CXCR2 (neutrophil chemoattractants and re-
ceptors). Similar gene expression changes were found in the
vhs virus-infected Stat1/ mice, although with delayed or
muted expression compared to that of the WT virus-infected
Stat1/ mice. Together, these gene products are strong
chemotactic signals that mediate immune cell infiltration
and are predictive of significant CNS inflammation. Several
other upregulated genes in the Stat1/ mice included the
cytokines interleukin 1 (IL-1) and IL-6, which influence
the integrity of the BBB (2, 38), the chemokine MCP-1,
which opens endothelial cell tight junctions (15, 20, 51), and
the enzymes MMP-3, -8, and -9, which degrade extracellular
matrix proteins at the BBB (43, 56). The altered expression
of these genes suggested that the integrity of the BBB was
being disrupted in the infected Stat1/ mice. To assess this,
we employed an Evans blue dye uptake assay in which dye
uptake into the CNS correlates with increased BBB perme-
ability (Fig. 4B). Coincident with the upregulation of cyto-
kines known to affect BBB permeability, we found increased
uptake of the dye in only the infected Stat1/ mice, re-
gardless of the viral strain and viral titer. Statistically signif-
FIG. 4. Pathogenicity genes and BBB permeability. (A) Heat map showing selected, differentially expressed genes within the cutoff values of
2-fold change and ANOVA P  0.01 in brain stems from WT virus-infected control mice, WT virus-infected Stat1/ mice, or vhs virus-infected
Stat1/ mice at 5 dpi. The numbers indicate fold changes compared to results for mock-infected mice. (B) Quantification of Evans blue dye in
brain tissue of infected mice. WT or vhs virus-infected control and vhs virus-infected Stat1/ mice are shown at 7 dpi. WT virus-infected
Stat1/ mice were moribund at 7 dpi, and so data are shown for 6 dpi. The amount of dye is reported in ng/brain. The dotted line indicates the
background level of Evans blue dye. *, P 
 0.01.
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icant changes were seen in the WT virus-infected Stat1/
mice (P 
 0.01). Increased uptake in the vhs-infected
Stat1/ mice occurred but was variable and not statistically
significant. These more variable increases correlate with the
variable viral titers seen at this time point (Fig. 1A) and the
delayed/muted increases in expression of BBB breach-re-
lated genes (Fig. 4). Increased BBB permeability was not
seen in infected mice lacking IFN receptors (P. C. Rosato
and D. A. Leib, unpublished data), indicating that the mu-
tation of Stat1, not the absence of IFN responses, was re-
sponsible for the BBB breach.
Multiplex cytokine and chemokine analysis. A bead-based
cytokine analysis was performed to confirm the inflammatory
and chemoattractant array profile in the brain stems. Both WT
and vhs virus-infected control mice showed little if any cy-
tokine or chemokine expression following infection (Fig. 5),
and results for them were similar to those for mock-treated
tissues. In contrast, the infected Stat1/ mice had sharp
increases in the cytokines IL-6, granulocyte colony-stimulat-
ing factor (G-CSF), and IFN-, as well as the chemoattrac-
tants macrophage inflammatory protein (MIP)-1 and
MCP-1 by 7 dpi. We also found modestly increased expres-
sion of IL-1, MIP-1, and IL-12p40 in the WT virus-in-
fected Stat1/ mice at 7 dpi. Expression of CXCL1 (also
known as KC and IL-8, a neutrophil chemoattractant),
peaked at 5 dpi in the Stat1/ mice. The most significant
changes in expression were found in the WT virus-infected
Stat1/ mice at 7 dpi, with elevated levels of all cytokines
and chemokines shown. Cytokine expression was not as dra-
matic in the vhs virus-infected Stat1/ mice at 5 and 7
dpi, with the exception of IL-1 expression. The chemokines
MIP-1, MCP-1, and KC are potent chemoattractants for
natural killer cells, monocytes, memory T cells, dendritic
cells, and neutrophils. The upregulation of these chemo-
kines is consistent with the array data, with appearance of
behavioral changes predictive of CNS disease and also pre-
FIG. 5. Bead-based cytokine analysis of brain stems. Control or Stat1/ mice were inoculated with 2  106 PFU/eye of HSV-1 WT or HSV-1
vhs. At the indicated time postinfection, protein was extracted from brain stem tissue and analyzed by bead-based cytokine analysis (n  4).
Cytokine concentrations are presented as pg/ml.
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dictive of immune cell migration and BBB breach in the
Stat1/ mice.
Histological analysis of infected brain stems. We evaluated
histological sections of infected brain tissues to overview the
location of viral antigen, immune cell infiltration, and the ex-
tent of tissue damage. We focused on the pons in the brain
stem directly adjacent to the trigeminal ganglia (Fig. 6A). Tis-
sue from the WT virus-infected control mice showed little if
any viral antigen in the brain stem and was indistinguishable
from mock-infected tissues (Fig. 6B and data not shown). In
contrast, viral antigen staining in the WT virus-infected
Stat1/ brain stems showed viral invasion as early as 5 dpi
(Fig. 6C). At 7 dpi, shortly before such mice succumb to in-
fection, the virus had penetrated deeper into the brain stem
and a significant immune cell infiltrate containing neutrophils
was readily apparent (Fig. 6D). The vhs virus was not as
invasive as the WT virus at 5 dpi (Fig. 6E), and by 7 dpi viral
antigen was mostly cleared. Despite this clearance, we ob-
served a persistent and massive immune cell infiltrate contain-
ing neutrophils (Fig. 6F). In the vhs virus-infected Stat1/
mice, disease symptoms and the immune cell infiltrate per-
sisted to at least 13 dpi (data not shown), long after vhs
clearance from the CNS (Fig. 1A) (35). Importantly, however,
neurological disease correlated with increased immune cell
infiltrates and not with viral antigen or CNS viral titer, as both
WT and vhs virus-infected Stat1/ mice exhibited similarly
severe and progressive patterns of neurological disease. This
observation is consistent with the upregulation of BBB perme-
ability-related genes in the vhs-infected brains (Fig. 4). Fur-
thermore, vhs still induced severe inflammation beyond the
clearance of infection, showing a pathological response to
HSV-1 infection in the brains of Stat1/ mice that was inde-
pendent of viral virulence or titer.
DISCUSSION
The efficacy of innate immunity and the early phase re-
sponse in the clearance of pathogens is dependent on several
factors, including efficient detection of pathogen-associated
molecular patterns (PAMPs), a measured IFN response, and
FIG. 6. Histological analysis of brain stem tissue. (A) Map taken from the Gene Expression Nervous System Atlas (GENSAT) Project
(www.gensat.org) shows the region of the brain examined in the subsequent panels. (B) Control mice infected with WT virus, 5 dpi. (C) Stat1/
brain infected with WT virus, 5 dpi. (D) Stat1/ mice infected with WT virus, 7 dpi. (E) Stat1/ mice infected with vhs virus, 5 dpi. (F) Stat1/
mice infected with WT virus, 7 dpi. Mice were inoculated with 2  106 PFU/eye of virus per eye, and brain stems were harvested and fixed for
histological analysis at times indicated. Tissue sections were stained for HSV-1 antigen (brown) and counterstained with hematoxylin. Represen-
tative images are shown of the pons area in the brain stem where the trigeminal ganglia connect to the brain stem.
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appropriate expression of chemoattractant cytokines. In this
study, we demonstrated the pivotal requirement for fully func-
tional Stat1 protein in the protection of the central nervous
system from an acute neurotropic virus infection. The in-
creased susceptibility of Stat1-deficient mice to CNS pathology
was mirrored in gene signatures that predicted significant per-
meability of the blood-brain barrier and dramatic increases in
expression of proinflammatory cytokines. These signatures
were subsequently authenticated through a series of biological
assays. Through parallel infection of control mice or the use of
an attenuated vhs virus in the Stat1/ mice, we were also
able to demonstrate protective signatures that resulted either
from subclinical infection or from disease and recovery. While
these infection scenarios resulted in a continuum of disease
determined by viral virulence and host susceptibility, these
gene signatures nevertheless demonstrate the delicate balance
between recovery, disease, and death during viral infection in
the CNS. Moreover, these signatures likely have strong corre-
lates in human disease, especially since defects in Stat1 are
correlated with susceptibility to HSV encephalitis (44).
It is notable in these data that while brain stems from both
control and Stat1/ mice upregulate chemokines in response
to infection, it is only the Stat1/ mice that show strong
upregulation of inflammatory markers, leukocyte adhesion
molecules, MMPs, and neutrophil chemotaxis genes. Notably
these increases are independent of viral antigen and titer.
Moreover, this profile is consistent with the previous finding
that type I IFN inhibits dendritic cell migration into the CNS
through Stat1-dependent suppression of MMP-9 and CCR7
expression (63). This previous finding provided mechanistic
insight into the established use of IFN- as a therapy for
multiple sclerosis by reducing dendritic cell migration into the
CNS, thereby helping to prevent demyelination. This previous
study, along with the central findings of this study, points to the
feasibility and potential efficacy of use of IFN- as a therapeu-
tic agent in combination with nucleoside analogs for treatment
of HSE.
The two major organs affected following generalized HSV
infection of immune-compromised mice and humans are the
brain and the liver. This analysis revealed dramatic differences
in IFN-dependent gene expression between the brain stems
and livers of the Stat1/ mice. Stat1/ mice clear the liver
infection, but not the CNS infection, with Stat1/ livers show-
ing a profile of IFN-dependent genes comparable to that found
in the CNS and liver of control mice. A potential explanation
for the expression of IFN-dependent genes in Stat1/ livers is
that Stat2-dependent signaling can be a source of interferon-
stimulated gene (ISG) expression in Stat1/ macrophages,
although this observation cannot explain the lack of signaling
in the CNS (37). Additionally, there could be a specific re-
quirement for Stat1 in the CNS or in neuronal cells or perhaps
differential effects of Stat1 and IFN in the CNS compared to
that in non-CNS tissues (59–61). Another possibility is that
there is heightened activation of Stat3 in Stat1/ cells, and
this may lead to pathological signaling in certain tissues (18, 32,
39, 58). Other research from our laboratory has revealed that
in a distinct Stat1-deficient mouse line (10), HSV follows a
more viscerotropic/hepatotropic pattern of spread. This im-
plies that the different domains or levels of activity of Stat1
may be influencing tropism (33). It is possible that the N-ter-
minal deleted Stat1/ strain used in this study (28) has suf-
ficient residual activity to protect the liver, but not the CNS,
from lethal infection. Notably, Stat1-deficient humans are
more susceptible to HSV encephalitis (9), implying that the
mouse strain used in this study (lacking the N terminus of
Stat1) is a better model for human disease than the mouse
strain lacking the DNA-binding domain (10). A further com-
parison of these two mouse lines will likely reveal important
details of Stat1 domains that determine host resistance to
infection.
A comparison of data from the present study with those
from a study of 129S6/SvEv mice infected with the highly
pathogenic avian H5N1 virus revealed that some of the genes
identified in the protective signature elicited in the HSV-in-
fected mice were components of a lethality signature elicited
during avian influenza virus infection (5). In contrast, some of
the genes identified as part of the molecular pathogenicity
signature associated with lethality in this study were also part
of a functional network associated with Ebola virus lethality in
other studies (4). Although these various studies differ in terms
of mice, viruses, inocula, and time points, an overarching pat-
tern is that interferon-dependent genes and inflammation-re-
lated genes play critical roles during lethal viral infection in
determining the delicate homeostatic balance of the immune
response and ultimately profoundly affect the fate of the host.
These findings may have therapeutic implications, suggesting
that compounds targeting these pathways may ameliorate se-
verity and outcomes of infections but only in a virus-specific
fashion. Study of virus- and tissue-specific protective and
pathogenicity signatures will therefore have great value in fash-
ioning predictions for therapeutic intervention in viral disease.
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